Moesin and CD44 expression in cutaneous melanocytic tumours (Q47833787)

6 February 2018

title

Moesin and CD44 expression in cutaneous melanocytic tumours (English)

1 reference

6 February 2018

author name string

Ichikawa T

1

1 reference

6 February 2018

Masumoto J

2

1 reference

6 February 2018

Kaneko M

3

1 reference

6 February 2018

Saida T

4

1 reference

6 February 2018

Sagara J

5

1 reference

6 February 2018

Taniguchi S

6

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

6 February 2018

British Journal of Dermatology

published in

1 reference

6 February 2018

volume

138

1 reference

6 February 2018

issue

5

1 reference

6 February 2018

page(s)

763-768

1 reference

6 February 2018

A heparin-binding protein involved in inhibition of smooth-muscle cell proliferation

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

Moesin: a member of the protein 4.1-talin-ezrin family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

ERM proteins: head-to-tail regulation of actin-plasma membrane interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

Moesin: a cell membrane protein linked with susceptibility to measles virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

Immunolocalization of CD44 and the ERM family in bone cells of mouse tibiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

CD44 and melanocytic tumors: a possible role for standard CD44 in the epidermotropic spread of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

CD44 expression in benign and malignant nevomelanocytic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.1998.02255.X

10.1046/J.1365-2133.1998.02255.X

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

9666819

1 reference

6 February 2018